SARS-CoV-2 multisystem inflammatory syndrome in an adult presenting with polyarthritis treated with anakinra

Rheumatology (Oxford). 2022 Feb 2;61(2):e33-e34. doi: 10.1093/rheumatology/keab697.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Arthritis / drug therapy*
  • Arthritis / virology*
  • COVID-19 / complications*
  • COVID-19 Drug Treatment*
  • Glucocorticoids / therapeutic use
  • Humans
  • Interleukin 1 Receptor Antagonist Protein / therapeutic use*
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • Pandemics
  • SARS-CoV-2
  • Systemic Inflammatory Response Syndrome / drug therapy*

Substances

  • Antirheumatic Agents
  • Glucocorticoids
  • Interleukin 1 Receptor Antagonist Protein
  • Methylprednisolone

Supplementary concepts

  • adult multisystem inflammatory disease, COVID-19 related